Specific Diagnostics
Mountain View, US · Delaware corporation · 1 known investors
Find your way into Specific Diagnostics
Sign up to see every warm intro you have to Specific Diagnostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Specific Diagnostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PR
Paul RhodesFounder
RM
Ray MartinoNamed on SEC filing
PG

Investors · 1
Telegraph Hill Partnerslisted by Telegraph Hill PartnersSan Francisco · $2M – $8M
How we know: Telegraph Hill Partners's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$17.5M disclosed across 1 round · 2019
▶$17.5MraisedFeb 2020 · 3 investors · Other Health CareRule 506(b)
▶$17.5MraisedFeb 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul RhodesExecutive Officer, Director
- Ray MartinoDirector
- Paul GrossmanDirector
- Offering amount
- $17.5M
- Amount sold
- $17.5M
- Minimum investment
- $1
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase I | 2021 | $248.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $145.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Specific Diagnostics?
- Specific Diagnostics was founded by Paul Rhodes.
- Who are Specific Diagnostics's investors?
- Specific Diagnostics's investors include Telegraph Hill Partners.
- How much funding has Specific Diagnostics raised?
- Specific Diagnostics has disclosed $17.5M raised across 1 round.
- Where is Specific Diagnostics headquartered?
- Specific Diagnostics is headquartered in Mountain View, US.
